Government buying Covishield at Rs 215, Covaxin at Rs 225 | India News
1 min read
[ad_1]
NEW DELHI: The fresh vaccine orders placed by the Centre are at a revised price of Rs 215 for Covishield and Rs 225 for a dose of Covaxin, according to an official source.
“We are on path to achieving the target of 50 crore doses by July 31, this is crucial towards meeting our target coverage by end of this year,” the senior official said. Nearly 40 crore doses were administered across the country till 10pm Friday.
While the Centre has indicated an availability of 13.5 crore doses for July, a fresh order of 66 crore doses for government procurement along with an additional advance payment already made by the Centre to reserve 30 crore doses of Biological E’s Covid vaccine are expected to boost supply.
While the Centre was earlier procuring vaccines at Rs 150 per dose, it had indicated that it will revise vaccine prices after the changed procurement plan came into effect from 21 June.
“The logistic management has to be linked at production and availability at field level, and while we appreciate the concern of states to get more vaccine doses, we must also appreciate how government of India is increasing production and parallelly ensuring that 75% of doses are given free of cost to states,” health ministry joint secretary Lav Agarwal said.
On availability of Moderna vaccine in the country, the government said talks are going on.
“We are on path to achieving the target of 50 crore doses by July 31, this is crucial towards meeting our target coverage by end of this year,” the senior official said. Nearly 40 crore doses were administered across the country till 10pm Friday.
While the Centre has indicated an availability of 13.5 crore doses for July, a fresh order of 66 crore doses for government procurement along with an additional advance payment already made by the Centre to reserve 30 crore doses of Biological E’s Covid vaccine are expected to boost supply.
While the Centre was earlier procuring vaccines at Rs 150 per dose, it had indicated that it will revise vaccine prices after the changed procurement plan came into effect from 21 June.
“The logistic management has to be linked at production and availability at field level, and while we appreciate the concern of states to get more vaccine doses, we must also appreciate how government of India is increasing production and parallelly ensuring that 75% of doses are given free of cost to states,” health ministry joint secretary Lav Agarwal said.
On availability of Moderna vaccine in the country, the government said talks are going on.
[ad_2]
Source
